A hierarchy of steps for the administration of high blood sugars control using an approach that balances age group and comorbidities while reducing the adverse effects of hypoglycemia and weight gain. Complications-centric treatment of the over weight or obese patient, as opposed to a body mass index -centric approach, including surgical and procedures for greater weight loss. Management of coronary disease risk elements, hypertension and hyperlipidemia in those patients with prediabetes or T2DM. Related StoriesBetalin launches brand-new EMP technology that could transform diabetes treatmentStudy discovers high prevalence of dehydration in older people living in UK care homesStudy explores diabetes screening for patients with severe mental illness Among the algorithm's essential recommendations is that a comprehensive care plan for persons with diabetes need to now consider obesity administration as a fundamental element of the overall treatment plan to effectively reduce morbidity, disability and mortality in nearly all patients with T2DM who all are obese.Other: Among the four individuals with additional IDH1 mutant positive solid tumors experienced stable disease. Investor Lunch and Webcast Info Agios will sponsor an investor lunch with Dr. Howard Burris today at 1:00 p.m. ET in Boston to review data shown at the conference. The function will become webcast live and can be accessed under Events & Presentations in the Investors and Media section of the company's website at A replay of the webcast will be archived on the Agios website for approximately 30 days following presentation. About Chondrosarcoma Chondrosarcoma is normally a heterogeneous band of cancers that arise from cartilage in the bone and joint. It is the most common type of bone malignancy with 700-1,000 people diagnosed per year in the U.S. IDH1/2 mutations happen in 40-50 % of central chondrosarcomas.